Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Moure-González M, Seoane-Blanco A, Varela-Román A, Alvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Eur J Heart Fail. 2010 Oct;12(10):1092-100. doi: 10.1093/eurjhf/hfq117. Epub 2010 Aug 3. Eur J Heart Fail. 2010. PMID: 20685687 Free article.
Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Moure-González M, Seoane-Blanco A, Varela-Román A, Almenar-Bonet L, Alvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Am J Cardiol. 2011 Mar 15;107(6):938-44. doi: 10.1016/j.amjcard.2010.11.011. Epub 2011 Jan 19. Am J Cardiol. 2011. PMID: 21247530
Evidence for a role of advanced glycation end products in atrial fibrillation.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Seoane-Blanco A, Moure-González M, Varela-Román A, Álvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Int J Cardiol. 2012 Jun 14;157(3):397-402. doi: 10.1016/j.ijcard.2011.05.072. Epub 2011 Jun 8. Int J Cardiol. 2012. PMID: 21652096
GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function.
Raposeiras-Roubín S, Aguiar-Souto P, Barreiro-Pardal C, López Otero D, Elices Teja J, Ocaranza Sanchez R, Cid Alvarez B, Trillo Nouche R, Maceiras MV, Abu-Assi E, García-Acuña JM, González-Juanatey JR. Raposeiras-Roubín S, et al. Angiology. 2013 Jan;64(1):31-9. doi: 10.1177/0003319711434800. Epub 2012 Feb 1. Angiology. 2013. PMID: 22297037
Advanced glycation end products: a mysterious shadow beyond the relationship between HbA1c and atrial fibrillation.
Raposeiras-Roubín S, Barreiro-Parda C, Roubín-Camiña F, Rodiño-Janeiro BK, Paradela-Dobarro B, Alvarez-Castro E, Grigorian-Shamagian L, González-Juanatey JR. Raposeiras-Roubín S, et al. Int J Cardiol. 2012 Jun 14;157(3):441. doi: 10.1016/j.ijcard.2012.04.002. Epub 2012 Apr 21. Int J Cardiol. 2012. PMID: 22525344 No abstract available.
237 results